James Paul Scopa, Director at Adverum Biotechnologies, Inc. (ADVM), bought 20,000 shares at $6.71 ($134K) on 2019-05-06, disclosed to the SEC on 2019-05-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| ADVM | SELL | 2021-11-17 | $218K | — | Filing → |
| DICE | BUY | 2021-09-16 | $102K | — | Filing → |
| ADVM | BUY | 2020-02-14 | $138K | — | Filing → |